Transnasal and standard transoral endoscopies in the screening of gastric mucosal neoplasias

doi:10.4253/wjge.v3.i8.162

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2845)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-4) series.

Item

Count

PDF

343

HTML

2268

Tables (1-4)

234

Sum=2845

Aug 16, 2011 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastrointest Endosc. Aug 16, 2011; 3(8): 162-170
Published online Aug 16, 2011. doi: 10.4253/wjge.v3.i8.162

Table 4 Screening performance of the two esophagogastroduodenoscopies according to the stages of Helicobacter pylori-related chronic gastritis (mean ± SD) n (%)

	Group A	Group B	Group C	Group D	Total subjects (H. pylori analyzed)
Screened by transnasal EGD
Screened subjects	572	189	321	198	1280
Age (yr)	45.3 ± 13.8	49.2 ± 14.6^c	59.8 ± 12.1^c	63.4 ± 12.8^c	53.4 ± 15.4
Males	257 (44.9)^a	74 (39.3)	194 (60.2)^a	98 (49.4)	623 (48.7)^a
Smokers	89 (15.6)^a	43 (22.8)^a	75 (23.3)	40 (20.2)	247 (19.2)
Subjects with gastric neoplasia/DR	0/0	1/0.0053^a^c	15/0.0466^c	5/0.0253	21/0.0164
Location of neoplasia (U/M/L)	0	0/1/0	4/5/6	3/0/2	7/6/8
Adenoma cases/DR	0/0	0/0	3/0.0093	0/0	3/0.0023
Size of adenoma (mm)	0	0	9.7 ± 4.0	0	9.7 ± 4.0
Cancer cases/DR	0/0	1/0.00532	12/0.0373	5/0.0253	18/0.0141
Size of cancer (mm)	0	5 ± 0	27.3 ± 12.3	46.0 ± 28.2	31.2 ± 19.5
Morphological cancer type (I-IIa/IIb/IIc-III/Ad)	0	0/0/1/0	5/0/3/4	1/1/0/3	6/1/4/7
With intestinal-type cancer	0 (0)	0/1 (0)	12/12 (100)	4/5 (80)	16/18 (88.9)
Depth of invasion (m/sm/pm-)	0	1/0/0	3/5/4	1/1/3	5/6/7
With early cancer	-	1 (100)	8 (66.7)	2 (40)	12 (66.7)
Screened by transoral EGD
Screened subjects	751	257	435	264	1707
Age (yr)	46.0 ± 12.6	46.6 ± 15.4	60.9 ± 11.8^c	64.0 ± 11.4^c	53.5 ± 15.4
Males	247 (32.9)	95 (37.0)	203 (46.7)	110 (41.7)	655 (38.4)
Smokers	167 (22.2)	39 (15.2)	102 (23.4)	46 (17.4)	354 (20.7)
Subjects with gastric neoplasia/DR	0/0	8/0.0311^c	18/0.0414^c	6/0.0227	32/0.0187
Location of neoplasia (U/M/L)	0	4/1/3	6/7/5	2/0/4	12/8/12
Adenoma cases/DR	0/0	2/0.00778	3/0.00689	4/0.0152	9/0.0052
Size of adenoma (mm)	0	7.5 ± 3.53	8.0 ± 13.9	10 ± 4.08	10.8 ± 7.9
Cancer cases/DR	0/0	6/0.0233	15/0.0345	2/0.00758	23/0.0134
Size of cancer (mm)	0	31.4 ± 12.1	19.4 ± 12.5	20 ± 0	22.3 ± 12.8
Morphological cancer type (I-IIa/IIb/IIc-III/Ad)	0	0/0/3/3	6/0/7/2	0/0/2/0	6/0/12/5
With intestinal-type cancer	0 (0)	2/6 (33.3)	12/15 (80)	1/2 (50)	16/24 (66.7)
Depth of invasion (m/sm/pm-)	0	2/1/3	11/2/2	2/0/0	15/3/5
With early cancer	-	3 (50)	13 (86.7)	2 (100)	18 (78.3)

^aP < 0.05 vs transoral;

^cP < 0.05 vs previous stage. H. pylori: Helicobacter pylori; DR: Detection rate; U: Upper third of the stomach; M: Middle third of the stomach; L: Lower third of the stomach; EGD: Esophagogastroduodenoscopy. Group A: H. pylori (-), chronic atrophic gastritis (CAG) (-); Group B: H. pylori (+), CAG (-); Group C: H. pylori (+), CAG (+); Group D: H. pylori (-), CAG (+).

Citation: Nakata H, Enomoto S, Maekita T, Inoue I, Ueda K, Deguchi H, Shingaki N, Moribata K, Maeda Y, Mori Y, Iguchi M, Tamai H, Yamamichi N, Fujishiro M, Kato J, Ichinose M. Transnasal and standard transoral endoscopies in the screening of gastric mucosal neoplasias. World J Gastrointest Endosc 2011; 3(8): 162-170
URL: https://www.wjgnet.com/1948-5190/full/v3/i8/162.htm
DOI: https://dx.doi.org/10.4253/wjge.v3.i8.162